Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degen… Read more
Nova EYE Medical Ltd (EYE) - Total Assets
Latest total assets as of December 2025: AU$23.67 Million AUD
Based on the latest financial reports, Nova EYE Medical Ltd (EYE) holds total assets worth AU$23.67 Million AUD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nova EYE Medical Ltd - Total Assets Trend (1989–2025)
This chart illustrates how Nova EYE Medical Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nova EYE Medical Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Nova EYE Medical Ltd's total assets of AU$23.67 Million consist of 46.5% current assets and 53.5% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$5.05 Million | 19.1% |
| Accounts Receivable | AU$4.18 Million | 15.8% |
| Inventory | AU$2.81 Million | 10.6% |
| Property, Plant & Equipment | AU$3.36 Million | 12.7% |
| Intangible Assets | AU$6.86 Million | 25.9% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (1989–2025)
This chart illustrates how Nova EYE Medical Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nova EYE Medical Ltd's current assets represent 46.5% of total assets in 2025, an increase from 35.7% in 1989.
- Cash Position: Cash and equivalents constituted 19.1% of total assets in 2025, up from 5.1% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 0.0% in 1989.
- Asset Diversification: The largest asset category is intangible assets at 25.9% of total assets.
Nova EYE Medical Ltd Competitors by Total Assets
Key competitors of Nova EYE Medical Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Nova EYE Medical Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Nova EYE Medical Ltd generates 1.10x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nova EYE Medical Ltd is currently not profitable relative to its asset base.
Nova EYE Medical Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.85 | 1.84 | 2.94 |
| Quick Ratio | 1.24 | 1.04 | 2.68 |
| Cash Ratio | 0.00 | 0.41 | 2.32 |
| Working Capital | AU$4.85 Million | AU$ 4.56 Million | AU$ 24.60 Million |
Nova EYE Medical Ltd - Advanced Valuation Insights
This section examines the relationship between Nova EYE Medical Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.61 |
| Latest Market Cap to Assets Ratio | 0.75 |
| Asset Growth Rate (YoY) | -11.3% |
| Total Assets | AU$26.50 Million |
| Market Capitalization | $19.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nova EYE Medical Ltd's assets below their book value (0.75 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Nova EYE Medical Ltd's assets decreased by 11.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nova EYE Medical Ltd (1989–2025)
The table below shows the annual total assets of Nova EYE Medical Ltd from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$26.50 Million | -11.30% |
| 2024-06-30 | AU$29.88 Million | -1.56% |
| 2023-06-30 | AU$30.36 Million | -17.11% |
| 2022-06-30 | AU$36.62 Million | -12.79% |
| 2021-06-30 | AU$41.99 Million | -64.03% |
| 2020-06-30 | AU$116.74 Million | +16.87% |
| 2019-06-30 | AU$99.89 Million | -3.45% |
| 2018-06-30 | AU$103.47 Million | +19.55% |
| 2017-06-30 | AU$86.54 Million | +20.21% |
| 2016-06-30 | AU$71.99 Million | +22.06% |
| 2015-06-30 | AU$58.98 Million | +8.76% |
| 2014-06-30 | AU$54.23 Million | +14.54% |
| 2013-06-30 | AU$47.35 Million | +5.37% |
| 2012-06-30 | AU$44.93 Million | -7.13% |
| 2011-06-30 | AU$48.38 Million | -6.20% |
| 2010-06-30 | AU$51.58 Million | +1.32% |
| 2009-06-30 | AU$50.91 Million | -29.24% |
| 2008-06-30 | AU$71.94 Million | +12.96% |
| 2007-06-30 | AU$63.69 Million | +37.03% |
| 2006-06-30 | AU$46.48 Million | +19.00% |
| 2005-06-30 | AU$39.05 Million | +1.93% |
| 2004-06-30 | AU$38.31 Million | +3.34% |
| 2003-06-30 | AU$37.08 Million | -4.37% |
| 2002-06-30 | AU$38.77 Million | +3283.99% |
| 2001-06-30 | AU$1.15 Million | +114.51% |
| 2000-06-30 | AU$534.07K | -5.82% |
| 1999-06-30 | AU$567.06K | -44.12% |
| 1998-06-30 | AU$1.01 Million | -41.42% |
| 1997-06-30 | AU$1.73 Million | -1.68% |
| 1996-06-30 | AU$1.76 Million | +43.73% |
| 1995-06-30 | AU$1.23 Million | +301.97% |
| 1994-06-30 | AU$305.00K | -44.04% |
| 1993-06-30 | AU$545.00K | -35.43% |
| 1992-06-30 | AU$844.00K | -29.55% |
| 1991-06-30 | AU$1.20 Million | -13.94% |
| 1990-06-30 | AU$1.39 Million | -64.11% |
| 1989-06-30 | AU$3.88 Million | -- |